EUVIMEDEUVIMED entdecken
Crossref

Hybrid Lipid Nanoparticles Containing Iron Oxide Nanoparticles and Doxorubicin

Igor V Zhigaltsev iD, Arash Momeni, Yao Zhang iD, Pieter R Cullis iD

Langmuir · 07.04.2026 · 42 (13) · 9193-9200

DOI: 10.1021/acs.langmuir.5c06286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Langmuir, online erschienen am 23.03.2026. Verfasst von Igor V Zhigaltsev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada. Hauptthemen laut MEDLINE: Doxorubicin, Magnetic Iron Oxide Nanoparticles, Lipids, Drug Carriers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinMagnetic Iron Oxide NanoparticlesLipidsDrug CarriersCholesterolPhosphatidylcholinesHydrophobic and Hydrophilic Interactions

Substanzen

DoxorubicinCholesterolPhosphatidylcholinesLipidsDrug Carriers

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
  • School of Biomedical Engineering, University of British Columbia, 6088 University Boulevard, Vancouver, BC V6T 1Z3, Canada.
  • Michael Smith Laboratories, University of British Columbia, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada.

ORCID-Profile: Igor V Zhigaltsev, Yao Zhang, Pieter R Cullis

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Zhigaltsev, I. V., Momeni, A., Zhang, Y., & Cullis, P. R. (2026). Hybrid Lipid Nanoparticles Containing Iron Oxide Nanoparticles and Doxorubicin. Langmuir, 42(13), 9193-9200. https://doi.org/10.1021/acs.langmuir.5c06286

Vancouver

Zhigaltsev IV, Momeni A, Zhang Y, Cullis PR. Hybrid Lipid Nanoparticles Containing Iron Oxide Nanoparticles and Doxorubicin. Langmuir. 2026;42(13):9193-9200. doi:10.1021/acs.langmuir.5c06286

BibTeX
@article{Zhigaltsev2026,
  author = {Zhigaltsev, Igor V and Momeni, Arash and Zhang, Yao and Cullis, Pieter R},
  title = {Hybrid Lipid Nanoparticles Containing Iron Oxide Nanoparticles and Doxorubicin},
  journal = {Langmuir},
  year = {2026},
  volume = {42},
  number = {13},
  pages = {9193--9200},
  doi = {10.1021/acs.langmuir.5c06286}
}
Kostenlos starten →